Search research articles
Contact Us
Filters
Showing results (31-40 of 736) with videos related to
Page
of 74
Sort By:
Journal of the American Heart Association
|
March 27, 2019
Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
Arthur Mark Richards
Canadian Journal of Physiology and Pharmacology
|
August 5, 2011
Tailored therapy for heart failure: neurohormones
A Mark Richards
Expert Opinion on Pharmacotherapy
|
November 16, 2011
Mineralocorticoid receptor antagonists for heart failure
Arthur Mark Richards
Evidence-Based Medicine
|
August 7, 2010
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
A Mark Richards
Hypertension (Dallas, Tex. : 1979)
|
April 25, 2007
Natriuretic peptides: update on Peptide release, bioactivity, and clinical use
A Mark Richards
Nature Reviews. Cardiology
|
October 17, 2018
Can heart failure cause cancer?
A Mark Richards
Journal of the American College of Cardiology
|
September 13, 2008
Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
A Mark Richards
Heart Failure Clinics
|
October 14, 2015
Biomarkers for Heart Failure in Asia
Arthur Mark Richards
Revista Espanola De Cardiologia (English Ed.)
|
November 9, 2015
Plasma Neprilysin Concentrations: A New Prognostic Marker in Heart Failure?
A Mark Richards
Annals of the Academy of Medicine, Singapore
|
October 20, 2015
Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?
Arthur Mark Richards
Page
of 74
Search research articles
Search
Showing results (31-40 of 736) with videos related to
Sort By:
Page
of 74
Journal of the American Heart Association
|
March 27, 2019
Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
Arthur Mark Richards
Canadian Journal of Physiology and Pharmacology
|
August 5, 2011
Tailored therapy for heart failure: neurohormones
A Mark Richards
Expert Opinion on Pharmacotherapy
|
November 16, 2011
Mineralocorticoid receptor antagonists for heart failure
Arthur Mark Richards
Evidence-Based Medicine
|
August 7, 2010
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
A Mark Richards
Hypertension (Dallas, Tex. : 1979)
|
April 25, 2007
Natriuretic peptides: update on Peptide release, bioactivity, and clinical use
A Mark Richards
Nature Reviews. Cardiology
|
October 17, 2018
Can heart failure cause cancer?
A Mark Richards
Journal of the American College of Cardiology
|
September 13, 2008
Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
A Mark Richards
Heart Failure Clinics
|
October 14, 2015
Biomarkers for Heart Failure in Asia
Arthur Mark Richards
Revista Espanola De Cardiologia (English Ed.)
|
November 9, 2015
Plasma Neprilysin Concentrations: A New Prognostic Marker in Heart Failure?
A Mark Richards
Annals of the Academy of Medicine, Singapore
|
October 20, 2015
Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?
Arthur Mark Richards
Page
of 74